Who is the CEO of BiVictriX Therapeutics Plc?

The CEO of BiVictriX Therapeutics Plc is Tiffany Jane Thorn.

What industry does BiVictriX Therapeutics Plc belong to?

BiVictriX Therapeutics Plc operates in the Biotechnology industry within the Healthcare sector.

Where is BiVictriX Therapeutics Plc headquartered?

BiVictriX Therapeutics Plc is headquartered at Bio Hub, Macclesfield, SK10 4TG, GB.

What is the IPO date of BiVictriX Therapeutics Plc?

BiVictriX Therapeutics Plc went public on August 11, 2021.

How many employees does BiVictriX Therapeutics Plc have?

BiVictriX Therapeutics Plc has approximately 17 full-time employees.

BiVictriX Therapeutics Plc

BVX.L•LSE

Healthcare

Biotechnology

£10.00

£1.50(17.65%)

BiVictriX Therapeutics Plc (BVX.L) Company Profile & Overview

Explore BiVictriX Therapeutics Plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

BiVictriX Therapeutics Plc (BVX.L) Company Profile & Overview

BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia. The company was formerly known as BiVictriX Plc and changed its name to BiVictriX Therapeutics Plc in August 2021. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.

SectorHealthcare

IndustryBiotechnology

CEOTiffany Jane Thorn

Contact Information

https://www.bivictrix.com

Bio Hub, Macclesfield, SK10 4TG

Company Facts

17 Employees

IPO DateAug 11, 2021

CountryGB

Frequently Asked Questions

;